Compare ResMed Inc. (RMD) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Williams-Sonoma, Inc. — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while Williams-Sonoma, Inc. trades at $223.2 (market cap $26.30B). The key difference: ResMed Inc. and Williams-Sonoma, Inc. are close in size by market cap, and Williams-Sonoma, Inc. pays the higher dividend (1.36%). Which is the better fit depends on your goals.
| RMD | WSM | |
|---|---|---|
Market Cap | $28.81B | $26.30B |
Sector | Health | Consumer Cyclical |
52-Week High | $293.73 | $240.06 |
52-Week Low | $182.82 | $168.64 |
Enterprise Value | $27.99B | $27.14B |
Dividend Yield | 1.21% | 1.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Williams-Sonoma (WSM) trades at $221.13, down 3.19% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company maintains strong profitability with a 13.81% net margin and 54.01% ROE, though revenue has shown volatility. Recent earnings beats and consistent dividend payments highlight operational strength amid consumer discretionary sector challenges noted in recent financial media coverage.
The outlook is mixed with solid fundamentals and analyst consensus near current price, but risks include consumer spending sensitivity and competitive pressures. Upside potential exists if earnings momentum continues, yet macroeconomic headwinds and sector underperformance pose near-term challenges for shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
